Introduction
Mitogen-activated protein kinase (MAPK) cascades have been conserved throughout all eucaryotic species to activate transcriptional programs in response to extracellular stimuli. MAPK proteins are proline-directed kinases, which phosphorylate downstream target proteins at consensus Ser/Thr Pro motifs (for review, see Pearson et al., 2001) . All organisms studied to date contain several different MAPK cascades, each of which is coupled to specific biologic responses, implying substrate specificity. This substrate specificity is achieved in part by a physical docking interaction, in which bona fide substrates associate with different MAPKs through residues distinct from the phosphoacceptor sites (Kallunki et al., 1996; Yang et al., 1998 Yang et al., , 1999 Jacobs et al., 1999; Fantz et al., 2001) . Docking motifs have been described for substrates of the mammalian MAPKs extracellular signal-regulated kinase (ERK), Jun N-terminal kinase (JNK), and p38. In each case, a leucine-based motif of the sequence LXL is present, and structure-function studies support the idea that the leucine residues together with the surrounding sequence are responsible for achieving specific docking interactions. This docking interaction is required for efficient phosphorylation both in vitro and in vivo, meaning that mutation of the docking site effectively uncouples the substrate from regulation by the MAPK.
The fact that catalytically inactive MAPKs can physically associate with their substrates leaves open the possibility that the docking interaction can serve a regulatory role different from directing efficient phosphorylation. One example of such a role is seen in the budding yeast Saccharomyces cerevisiae, which utilizes the MAPK Kss1p to regulate the invasive growth pathway (Cook et al., 1997; Madhani et al., 1997; Bardwell et al., 1998a, b) . Kss1p regulates and phosphorylates the transcription factor Ste12p, which directly binds to DNA sequences within the filamentation response element (FRE) to direct invasive growth. Genetic evidence strongly indicates that Kss1p regulates invasive growth by repression of Ste12p using a mechanism that is dependent on the docking interaction between Kss1p and Ste12p, but not on the kinase activity of Kss1p. Thus, precedent exists for the notion that MAPKs can regulate the function of their substrates by mechanisms that rely on the docking interaction, but are independent of catalytic activity.
The activity of the transcription factor c-Jun is regulated by the JNK family of MAPK proteins (Adler et al., 1992; Hibi et al., 1993; Pulverer et al., 1993; Derijard et al., 1994; Dai et al., 1995) . The JNK pathway is activated in response to stress stimuli (heat shock, protein synthesis inhibitors, osmoregulatory pressure) as well as inflammatory cytokines (TNF-a and IL-1). When stimulated, JNK phosphorylates c-Jun on serines 63 and 73 to activate the transcriptional properties of c-Jun (Pulverer et al., 1991; Smeal et al., 1992) . Efficient phosphorylation of c-Jun by JNK requires the integrity of a region amino terminal to the phosphorylation sites that serves as a docking domain (Pulverer et al., 1993; Dai et al., 1995; Kallunki et al., 1996; May et al., 1998a) (Figure 1 ). As with other MAPK docking domains, the association of JNK with c-Jun is independent of the state of JNK catalytic activity (Kallunki et al., 1994 (Kallunki et al., , 1996 May et al., 1998a) .
c-Jun was discovered as the cellular progenitor of the oncogenic viral protein v-Jun (Maki et al., 1987) . A comparative analysis of the transforming properties of v-Jun and c-Jun indicated that a major determinant of the enhanced oncogenic potential of v-Jun is the presence of an in-frame deletion of 27 amino acids near the amino-terminus of the protein (Bos et al., 1990) . Subsequent work revealed that this region, referred to as the delta domain, serves as a docking domain on Jun proteins for the JNK family of MAPKs (Adler et al., 1992; Hibi et al., 1993; Kallunki et al., 1996; May et al., 1998a) . As a consequence of this deletion, v-Jun is a poor substrate for JNK and is effectively uncoupled from JNK-dependent phosphorylation. These observations suggest that the oncogenic effect of the deltadomain deletion is to uncouple v-Jun from JNK signaling. Consistent with this idea, several pieces of evidence support the idea that the catalytic activity of JNK is not a positive regulator of the transforming potential of Jun proteins: (1) v-Jun is phosphorylated on serines 63 and 73, the sites of JNK phosphorylation, to very low levels in v-Jun transformed cells; (2) mutation of serines 63 and 73 in v-Jun does not alter its transforming potential; and (3) cell transformation occurs in the setting of very low levels of JNK activity (i.e. in the absence of stimulation of the JNK pathway) (Black et al., 1994; Kilbey et al., 1996; Ui et al., 1998) . Taken together, these data suggest that if JNK suppresses cellular transformation by Jun proteins, it is likely to be by a docking mechanism similar to that observed in the invasive growth pathway in budding yeast, and independent of JNK catalytic activity.
In this paper, we describe by way of two tests of the model that it is the uncoupling of Jun from JNK signaling that underlies the increased oncogenic potential of Jun proteins with a deletion of the delta domain. Using overexpression of JNK as well as a detailed mutational analysis of the delta domain, we find that deletion of the JNK docking site is not the basis by which the delta domain regulates the transforming potential of Jun proteins. Furthermore, we identify a cluster of residues in c-Jun in which mutation to alanine results in Jun proteins that are strongly activated for transformation, but in which Jun-JNK signaling is unaffected. The results imply that the oncogenic effect of the delta domain is not a consequence of uncoupling Jun from JNK signaling and imply the existence of a different and unidentified regulator of Jun transforming activity.
Results

Deletion of the delta domain disrupts docking and activates transformation by c-Jun
To evaluate the role of JNK docking in the regulation of transformation by c-Jun proteins, we first defined the limits of the docking domain. For this analysis, we utilized the JNK2a isoform as it has previously been shown to display strong binding to Jun (Kallunki et al., 1994; Gupta et al., 1996) . An amino-terminal region of mouse c-Jun containing the first 110 amino acids was expressed as a GST fusion protein in Escherichia coli and bound to glutathione Sepharose. GST or GST-Jun proteins bound to beads were then incubated with extracts prepared from 293 cells that had been transiently transfected with an HA-JNK2a expression plasmid. The amount of JNK2a that was bound to the beads was then determined by immunoblotting. The results show that GST-Jun (1-110) is able to bind JNK2a, while a GST-Jun fusion protein that harbors a deletion of the delta domain completely abrogates binding to JNK2a (Figure 2a) . Furthermore, amino acids 33-55 of mouse c-Jun are sufficient to bind JNK2a at levels comparable to the first 110 amino acids of c-Jun in vitro, while further truncation from either the amino-terminus (to amino acid 36) or carboxyl-terminus (amino acid 52) was unable to support efficient binding (Figure 2a ). The association is not dependent on kinase activity, as HA-JNK2 from unstimulated cells associates with GST-Jun more readily than activated JNK from UV-treated cells (Figure 2b ). Therefore, activation of JNK2 is not required for its association with the delta domain. These data define the limits of the JNK docking domain in cJun as lying between amino acids 33 and 55.
GST-Jun and GST-JunD were then tested for their ability to function as JNK substrates in vitro. HA-JNK was immunoprecipitated from transiently transfected 293 cells that had been activated by UV irradiation. GST fusion proteins were incubated with the Figure 2c ). These data are consistent with previously published results and demonstrate that the delta domain is required for both docking and efficient phosphorylation (Adler et al., 1992; Hibi et al., 1993; Kallunki et al., 1994 Kallunki et al., , 1996 .
Although the delta-domain deletion is necessary for efficient v-Jun transformation, other changes, including point mutations in the bZIP domain, also contribute to the oncogenicity of the protein. To define the role of the delta-domain deletion alone in regulating Jun transformation, we used recombinant RCAS retroviruses to direct expression of wild-type and mutant mouse Jun proteins in chick embryo fibroblasts (CEFs), a cell type susceptible to transformation by Jun (Cavalieri et al., 1985; Castellazzi et al., 1990; May et al., 1998b) . All of the Jun proteins were expressed at equivalent levels in CEFs as measured by immunoblots from infected cells (Figure 3a) . To determine the level of transforming activity, cells were seeded in soft agar and colonies were counted after 10-14 days. All of the Jun proteins were capable of directing colony formation in soft agar at levels greater than either uninfected CEFs or CEFs expressing an irrelevant protein (alkaline phosphatase, AP). Deletion of the delta-domain increased soft agar colony formation two fold above mouse c-Jun levels, but mutation of S63/73 to alanine did not augment the transforming potential of c-Jun (Figure 3b , c and Table 1 ). These results are consistent with previously published data that defined the role of the delta domain in regulating transformation by c-Jun. Furthermore, they suggest that if JNK represses c-Jun transformation, it does so by a mechanism that does not require the presence of the JNK phosphorylation sites on c-Jun. We therefore focused our attention on the role of the docking interaction as a potential regulator of transformation.
Coexpression of JNK2 does not suppress the transforming activity of RCAS-c-Jun
If JNK functions as a repressor of c-Jun transforming activity by a docking mechanism, then overexpression of JNK should suppress the residual transforming activity of c-Jun, but not of c-Jun mutants that disrupt docking. To define the ability of JNK to repress cellular transformation by c-Jun, we coexpressed the two proteins in CEF cells. Expression of JNK from RCAS vectors was inefficient (data not shown), so we utilized the system of Akagi et al. (2000) , in which replication defective Mu-MLV-based vectors are pseudotyped with RSV envelope protein. Infected cells were selected in G418 and HA-JNK2 expression was analysed by immunoblot ( Figure 4a ). With this system, we were able to achieve levels of HA-JNK2 expression that were significantly increased compared to vector-infected cells.
The JNK-expressing cells were then infected with either RCAS-c-Jun or RCAS-v-Jun virus. Western blot of extracts from the dually infected cells showed that HA-JNK2 did not influence the expression of c-Jun (Figure 4a ). The cells were seeded in soft agar, and after 14 days the number of colonies were counted and compared (Figure 4b ). Expression of HA-JNK2 did not impair the transforming ability of either wild-type c-Jun or v-Jun (or other Jun proteins that were tested, data not shown).
Point mutations affect JNK2 binding and IP kinase activity in vitro
As a second way of defining the role of the docking interaction in Jun transformation, we carried out a mutational analysis of the delta domain. Previously published work identified amino acids L40, L42, L49, and K50 as residues within the delta domain important for JNK binding and phosphorylation (Kallunki et al., 1996; Yang et al., 1998) . To further delineate the requirements for JNK binding, a panel of point mutations was generated within the delta domain of cJun and tested for binding HA-JNK2a using the pulldown assay described above. The results show that point substitutions in several different amino acids influence the ability of JNK to dock c-Jun ( Figure 5 ). In particular, mutation of residues K32, K35, and L40/42 in the c-Jun delta domain all resulted in significant reductions in JNK binding. Interestingly, none of the mutants showed enhanced binding to JNK.
Each of the point mutants was then tested as a JNK substrate by IP kinase assay. All Jun mutants that were significantly impaired for JNK docking were also impaired as JNK substrates. Furthermore, the magnitude of the defects were strongly correlated ( Figure 5 ). Only three mutants were an exception to this general rule: R54A, K56A/H52Y, and N57A. As GST fusion proteins, they bind JNK between 50% and 100% of wild type, but are modestly more efficiently phosphorylated in vitro than wild-type GST-Jun. Overall, the results are consistent with the model that JNK binding is required for efficient c-Jun phosphorylation and further define the residues required for the Jun delta domain to bind JNK (Adler et al., 1992; Hibi et al., 1993; Yang et al., 1998) .
Disruption of the docking interaction does not correlate with transformation
If JNK docking represses c-Jun transformation, point mutants defective in JNK binding would be expected to demonstrate increased transforming activity. To test this idea, recombinant RCAS viruses were generated for several of the point mutants and used to infect CEFs. Western blot analysis showed that the mutant proteins are expressed at similar levels in CEFs (Figure 6a ). The cells were seeded in soft agar and assayed for their ability to form colonies as before (Figure 6b and Table 1 ). In general, there was a poor correlation between JNK docking and transformation. Two mutants with substitutions that alter the leucine motif conserved among many MAPK docking domains (L40/ 42A and 40/42/49/50A) are completely defective in JNK docking and as JNK substrates in vitro, but are not activated for cellular transformation. In contrast, three mutants near the C-terminal end of the delta domain (R54A, K56A/H52Y, and L61A) show normal or nearly normal levels of JNK docking and phosphorylation in vitro, yet are highly activated for transformation ( Figure 6b and Table 1 ). In each case, the activated Jun mutants induced an invasive agar colony morphology that is typical of v-Jun-transformed cells, while the morphology of c-Jun-expressing colonies is more compact. Several other mutants that display normal levels of JNK docking in vitro show levels of transforming activity that are similar to wild-type c-Jun (for example, I33A).
The JNK-Jun interaction is not sufficiently stable in vivo to allow detection by, for example, coimmunoprecipitation. However, it has previously been shown that mutant Jun proteins that are unable to dock JNK are poorly phosphorylated in vivo after JNK activation by UV (Adler et al., 1992; Kallunki et al., 1996) . To determine the extent to which the docking measurements obtained in vitro would be reflected in vivo, we examined the UV-induced phosphorylation of the different Jun proteins in infected cells. After treatment with UV light (60 J/m 2 ), Western blots were performed with antibodies to c-Jun or c-Jun phosphorylated on Ser 63 (P-63) and Ser 73 (P-73) (Figure 7) . The results were entirely consistent with the docking efficiency defined by the pull-down assays. The docking defective mutants cJunD, L40/42A, and 40/42/49/50A, all showed a marked decrease in UV-induced phosphorylation in vivo; in contrast, K50A, R54A, K56A/H52Y, and L61A were all phosphorylated to approximately wild-type levels. The results suggest that the docking relations defined in vitro pertain to that defined in vivo, and further emphasize the lack of a relation between JNK docking and cellular transformation.
Effect of delta-domain mutations on c-Jun transcriptional activity
Although Jun functions as an oncoprotein by altering gene expression, the mechanisms responsible remain poorly understood. Specifically, the ability of Jun proteins to activate consensus AP-1 reporters does not correlate with their ability to elicit cellular transformation (Havarstein et al., 1992) . More recently, it has been coli and purified on glutathione Sepharose. The ability of each mutant to bind HA-JNK2 was determined using the pull-down assay described above. In addition, the ability of each mutant to serve as a JNK substrate was determined using the IP kinase assay described in Figure 1 . The analysis was carried out at least three times for each mutant; representative images are shown demonstrated that the chick heparin binding-epidermal growth factor (HB-EGF) gene is a target of v-Jun action that is preferentially responsive to transforming Jun proteins, although the molecular basis for this observation is not known (Fu et al., 1999) . To examine the role of JNK docking on expression of HB-EGF mRNA, we performed Northern blots using RNA samples derived from CEFs expressing the different c-Jun mutant proteins (Figure 8) . The results show that although all of the Jun proteins activate expression of HB-EGF mRNA, mutations that affect either JNK docking or Jun transforming activity do not preferentially enhance the expression of HB-EGF mRNA. We conclude that the ability of transforming Jun proteins to activate HB-EGF mRNA expression is not tightly correlated with function of the delta domain. In addition, this analysis demonstrates that the mutants L40/42A and 40/42/49/ 50A, which do not demonstrate strong transforming activity, retain the ability to induce expression of HB-EGF. This strongly suggests that these mutations do not impair the ability of c-Jun to activate expression of at least some target genes; therefore, these mutant proteins are competent to carry out some Jun functions.
Discussion
MAPK proteins directly control transcription factor function through positive regulatory phosphorylation. Additionally, it is clear that in the case of the Kss1p MAPK from budding yeast, docking of the catalytically inactive form of Kss1p is associated with regulatory functions. The conserved nature of MAPK cascades, as well as the fact that deletion of the docking domain in vJun contributes to the oncogenicity of the protein, has suggested that JNK functions as a suppressor of transformation by Jun (Bardwell et al., 1998a; Havarstein et al., 1992) . However, we provide several lines of evidence that such a model is not correct. First, overexpression of JNK does not suppress the ability of c-Jun to elicit cellular transformation. Second, point mutations within the docking domain (L40/42A and 40/ 42/49/50A), which completely impair docking, do not generate Jun proteins that are activated for transformation. While it could be argued that these mutations disrupt the overall function of the protein, this is unlikely to be true: both proteins are expressed at levels similar to the wild-type protein, and expression of both proteins in CEFs leads to increased levels of HB-EGF mRNA, a gene that is probably a direct target of Jun activation (Fu et al., 1999; Vogt, 2001 ). Third, several Figure 4 and data not shown). Quantitation was performed by carrying out Western blots using serial dilutions of the JNK2 bound to GST-Jun as a quantitative standard b Detection of c-Jun phosphoserine 73 in vivo after UV treatment was as described in Figure 7 ND: not done mutants that display essentially normal JNK-Jun interaction and JNK-directed phosphorylation are activated for transformation. While we cannot exclude the possibility that there are subtle differences in the abundance of different phosphoisomers, the results suggest that perturbation of the JNK-Jun interaction is not a feature of activated mutants. It is possible to interpret the effects of some previously described mutations in light of these new data. Specifically, Havarstein et al. (1992) have generated a number of smaller deletions within the delta domain. The mutant cJ-3-23 harbors a deletion of amino acids 35-48, removing the leucine motif that is required for JNK docking; this mutant is impaired for transformation rather than activated. The mutant cJ-3-34 removes amino acids 47-54; this mutant, which is activated for transformation, is also likely to be defective for JNK docking. Thus, these previous results are consistent with our observations that disruptions in the C-terminal end of the delta domain, rather than disruptions of the JNK-Jun interaction, generate alleles that are activated for transformation. While these results argue that JNK docking does not regulate the transforming function of Jun, the results do not exclude the possibility that docking provides a regulatory function in some other aspect of Jun function. That the highly transforming point mutants are all clustered at the Cterminus of the delta domain suggests that an additional factor is dependent on the integrity of that region to control transforming activity. Whether this is a property inherent to c-Jun structure or is regulated by an unidentified molecule remains to be determined. Previously published work has described activities or molecules, including JAB1, that interact with the c-Jun activation domain to alter its transcriptional properties (Baichwal and Tjian, 1990; Baichwal et al., 1992; Claret et al., 1996) . The ability of these molecules to regulate the oncogenic potential of proteins remains uncharacterized, as are the precise sequences on c-Jun that are required for the interaction.
The JNK docking domain on c-Jun can promote trans-phosphorylation of dimerization partners such as JunD, which do not contain a functional docking domain of their own, by recruiting JNK to a heterodimeric Jun : JundD complex. Whether such an interaction could underlie a role for JNK in the regulation of transformation awaits further analysis. The simplest interpretation of our data would suggest that JNK does not play a significant role. However, the transformation of rat embryo fibroblasts by Jun plus activated ras has been shown to be dependent on the presence of serines 63 and 73 in c-Jun (Smeal et al., 1991) . Therefore, our data do not exclude a role for JNK in the regulation of transformation by c-Jun in other cellular contexts.
Materials and methods
Plasmids and mutagenesis
A mouse c-jun was cloned into the plasmid SKÀ such that 27 nucleotides of untranslated 5 0 sequence and 102 nucleotides of the 3 0 untranslated end were included with the full-length coding sequence. The SKÀ polylinker was then modified by insertion of an additional ClaI site between NotI and BamHI. This resulted in a plasmid in which the c-jun sequence is flanked by two ClaI sites. c-Jun was then shuttled into the RCASA vector as a ClaI fragment. Both oligonucleotidemediated and polymerase chain reaction (PCR)-directed mutagenesis were used to generate mutations in mouse c-jun. Mutations were confirmed by sequencing before transfer to RCASA. Constructs expressing the GST-c-Jun protein were generated by PCR amplification of the sequences encoding cJun amino acids 2-110 using the primers 5 0 -CCCGAATT-CACTGGAAAGATGGAAACGACC-3 0 (forward) and 5 0 -CCCTCTAGACCCCTAGAAGCCCTCCTGCTCGTCGGT-CAC-3 0 (back). Fragments were cloned into a modified pGEX-KG vector, C-terminal to the GST coding sequence. The pCXneo vector as well as the RSV envelope expression plasmid RNA from CEFs expressing the indicated mutants was analysed for the expression of HB-EGF mRNA by Northern blotting. The level of expression for each mutant was quantitated by Phosphoimager analysis and the relative expression level, normalized to GAPDH expression, is shown were a generous gift from T Akagi. An HA-tagged human JNK2 cDNA fragment was inserted into the vector pCX-neo to generate retrovirus directing JNK2 expression.
Cells and viruses
A total of 293 cells and Phoenix cells were grown in DMEM supplemented with fetal calf serum and antibiotics. CEFs were obtained from SPAFAS and grown in M199 media supplemented with 10% fetal calf serum, 5% chicken serum, 10% tryptose phosphate broth, and antibiotics.
Mu-MLV-based replication defective viruses were prepared by transfecting either pCX-neo or pCX-HA-JNK2 along with an RSV-env expression plasmid into Phoenix packaging cells using Lipofectamine (Gibco) (Akagi et al., 2000) . The pCX vectors express the G418 resistance gene from a bicistronic mRNA using an IRES. CEFs were infected with the pseudotyped virus and selected with G418 at a concentration of 300 mg/ml. RCAS (subgroup A)-based viruses were generated by transfecting CEFs with RCAS plasmids. After passage to allow spread, high titer stocks were collected and used to infect primary CEFs.
For soft-agar colony assays, infected cells were seeded at a density of 7.5 Â 10 3 /ml in 0.4% Sea Plaque agarose/CEF media on a layer of 0.8% Sea Plaque/CEF media. Samples were seeded in triplicate and incubated for 14 days. Photographs of each dish were taken by CCD camera, and the total number of colonies >90 mm was counted for each photograph. For each Jun mutant, at least two experiments in triplicate were performed. Although the number of colonies varied from experiment to experiment, the fold differences were consistent.
JNK docking and kinase assays
For docking assays, GST-cJun fusion proteins expressed in E. coli were bound to glutathione agarose. Beads harboring 5 mg of each fusion protein were incubated with extracts prepared in 20 mm HEPES, pH 7.7, 50 mm NaCl, 1 mm EDTA, and 0.05% Triton X-100 from 293 cells transiently expressing HA-JNK2. The beads were washed in the buffer described above and the bound HA-JNK2 was eluted with Laemmeli buffer, and detected by immunoblotting with an HA antibody. To quantitate the reduction in JNK binding of GST-K35A, L40/42A, K50A, L40/42/49/K50A, R54A, and R54A/A55R, the amount of HA-JNK bound by each mutant was compared to serial dilutions of HA-JNK bound by GST-110 by immunoblot.
For in vitro kinase assays, extracts were prepared from 293 cells expressing HA-JNK2 and stimulated with 60 J/m 2 of UV. HA-JNK2 was immunoprecipitated with anti-HA bound to Protein A agarose. After washing, the HA-JNK2-bound beads were incubated for 20 min at 301C with 3 mg eluted GST-Jun fusion protein, 20 mm ATP, and 5 mCi 32 P ATP in a total volume of 30 ml kinase buffer (25 mm HEPES pH 7.6, 20 mm MgCl 2 , 20 mm b-glycerol phosphate). Reactions were terminated with 2 Â Laemmeli buffer, samples separated by SDS-PAGE, and the dried gel was exposed to film.
Immunoblots
To detect JNK, CEFs infected with virus expressing the indicated viruses were either treated or not treated with 60 J/m 2 of UV. After 20 min, whole-cell extracts were prepared and expression of HA-JNK was detected with antibody directed against HA. For c-Jun, P-63 c-Jun, and P-73 c-Jun, nuclear extracts were prepared either before or 20 min after UV. Antibodies were obtained from Covance (mouse monoclonal against HA), Santa Cruz (H79, polyclonal antibody directed against c-Jun amino acids 1-79), and Cell Signaling (polyclonal antibodies directed against phosphoserines 63 and 73). Note that both chicken c-Jun and v-Jun react poorly with the antibody against c-Jun.
